SEC Info℠  
    Home      Search      My Interests      Help      Sign In      Please Sign In

Intercept Pharmaceuticals, Inc. – ‘8-K’ for 9/26/23 – ‘EX-101.SCH’

On:  Tuesday, 9/26/23, at 8:28am ET   ·   For:  9/26/23   ·   Accession #:  1104659-23-103739   ·   File #:  1-35668

Previous ‘8-K’:  ‘8-K’ on / for 8/2/23   ·   Next & Latest:  ‘8-K’ on / for 11/8/23   ·   3 References:   

Find Words in Filings emoji
 		  in    Show  and   ↓Hints

  As Of               Filer                 Filing    For·On·As Docs:Size             Issuer                      Filing Agent

 9/26/23  Intercept Pharmaceuticals, Inc.   8-K:1,8,9   9/26/23   12:986K                                   Toppan Merrill/FA

Current Report   —   Form 8-K

Filing Table of Contents

Document/Exhibit                   Description                      Pages   Size 

 1: 8-K         Current Report                                      HTML     52K 
 2: EX-2.1      Plan of Acquisition, Reorganization, Arrangement,   HTML    591K 
                Liquidation or Succession                                        
 3: EX-99.1     Miscellaneous Exhibit                               HTML     39K 
 7: R1          Cover                                               HTML     46K 
10: XML         IDEA XML File -- Filing Summary                      XML     12K 
 8: XML         XBRL Instance -- tm2326902d1_8k_htm                  XML     15K 
 9: EXCEL       IDEA Workbook of Financial Report Info              XLSX      8K 
 5: EX-101.LAB  XBRL Labels -- icpt-20230926_lab                     XML     96K 
 6: EX-101.PRE  XBRL Presentations -- icpt-20230926_pre              XML     64K 
 4: EX-101.SCH  XBRL Schema -- icpt-20230926                         XSD     12K 
11: JSON        XBRL Instance as JSON Data -- MetaLinks               25±    35K 
12: ZIP         XBRL Zipped Folder -- 0001104659-23-103739-xbrl      Zip    160K

‘EX-101.SCH’   —   XBRL Schema — icpt-20230926

This Exhibit is an XBRL File.

                                                                                                                                                                                
<?xml version="1.0" encoding="windows-1252"?>
<!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 5.19c -->
<!-- Field: Doc-Info; Name: VendorURI; Value: https://www.novaworks.com -->
<!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
<!-- Field: Doc-Info; Name: Misc; Value: +aA5w7xRiXgen8uLa3ZcWa2NObOdzZR+SYkxtmB0bXlqHyoqLVyzASNaidHGcZ8G -->
<schema xmlns="http://www.w3.org/2001/XMLSchema" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:dei="http://xbrl.sec.gov/dei/2023" xmlns:us-gaap="http://fasb.org/us-gaap/2023" xmlns:srt="http://fasb.org/srt/2023" xmlns:srt-types="http://fasb.org/srt-types/2023" xmlns:icpt="http://interceptpharma.com/20230926" elementFormDefault="qualified" targetNamespace="http://interceptpharma.com/20230926">
<annotation>
<appinfo>
<link:roleType roleURI="http://interceptpharma.com/role/Cover" id="Cover">
<link:definition> 00000001 - Document - Cover </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:linkbaseRef xlink:type="simple" xlink:href="icpt-20230926_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:title="Presentation Links"/>
<link:linkbaseRef xlink:type="simple" xlink:href="icpt-20230926_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:title="Label Links"/>
</appinfo>
</annotation>
<import namespace="http://www.xbrl.org/2003/instance" schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd"/>
<import namespace="http://www.xbrl.org/2003/linkbase" schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd"/>
<import namespace="http://xbrl.sec.gov/dei/2023" schemaLocation="https://xbrl.sec.gov/dei/2023/dei-2023.xsd"/>
<import namespace="http://fasb.org/us-gaap/2023" schemaLocation="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd"/>
<import namespace="http://fasb.org/us-types/2023" schemaLocation="https://xbrl.fasb.org/us-gaap/2023/elts/us-types-2023.xsd"/>
<import namespace="http://www.xbrl.org/dtr/type/2022-03-31" schemaLocation="https://www.xbrl.org/dtr/type/2022-03-31/types.xsd"/>
<import namespace="http://xbrl.sec.gov/country/2023" schemaLocation="https://xbrl.sec.gov/country/2023/country-2023.xsd"/>
<import namespace="http://fasb.org/srt/2023" schemaLocation="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd"/>
<import namespace="http://fasb.org/srt-types/2023" schemaLocation="https://xbrl.fasb.org/srt/2023/elts/srt-types-2023.xsd"/>
</schema>

3 Subsequent Filings that Reference this Filing

  As Of               Filer                 Filing    For·On·As Docs:Size             Issuer                      Filing Agent

11/08/23  Intercept Pharmaceuticals, Inc.   8-K:1,2,3,511/08/23   16:493K                                   Toppan Merrill/FA
11/06/23  Intercept Pharmaceuticals, Inc.   10-Q        9/30/23   80:10M                                    Toppan Merrill Bridge/FA
10/11/23  Alfasigma S.p.A.                  SC TO-T               16:3.6M Intercept Pharmaceuticals, Inc.   Toppan Merrill/FA
↑Top
Filing Submission 0001104659-23-103739   –   Alternative Formats (Word / Rich Text, HTML, Plain Text, et al.)
Copyright © 2024 Fran Finnegan & Company LLC – All Rights Reserved.
About — Privacy — Redactions — Help — Thu., May 16, 2:24:42.1am ET